California State Teachers Retirement System (CalSTRS)’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Buy
61,306
+18,806
+44% +$418K ﹤0.01% 1699
2025
Q4
$1.1M Sell
42,500
-124
-0.3% -$2.95K ﹤0.01% 1756
2025
Q3
$1.1M Buy
42,624
+2
+0% +$49 ﹤0.01% 1739
2025
Q2
$1.02M Sell
42,622
-501
-1% -$12.6K ﹤0.01% 1738
2025
Q1
$1.07M Hold
43,123
﹤0.01% 1659
2024
Q4
$812K Sell
43,123
-835
-2% -$14.7K ﹤0.01% 1881
2024
Q3
$662K Sell
43,958
-1,369
-3% -$23.4K ﹤0.01% 1997
2024
Q2
$1.3M Sell
45,327
-1,025
-2% -$29.2K ﹤0.01% 1628
2024
Q1
$1.35M Sell
46,352
-2,707
-6% -$83.2K ﹤0.01% 1642
2023
Q4
$1.66M Sell
49,059
-1,646
-3% -$48.2K ﹤0.01% 1560
2023
Q3
$1.56M Sell
50,705
-4,884
-9% -$176K ﹤0.01% 1536
2023
Q2
$2.23M Sell
55,589
-1,434
-3% -$59.3K ﹤0.01% 1427
2023
Q1
$2.33M Sell
57,023
-788
-1% -$31.3K ﹤0.01% 1386
2022
Q4
$2.23M Buy
57,811
+768
+1% +$37.4K ﹤0.01% 1412
2022
Q3
$3.03M Sell
57,043
-532
-0.9% -$29.6K 0.01% 1186
2022
Q2
$3.36M Buy
57,575
+777
+1% +$50.9K 0.01% 1195
2022
Q1
$4.33M Sell
56,798
-4,869
-8% -$325K 0.01% 1139
2021
Q4
$3.71M Buy
61,667
+2,157
+4% +$119K ﹤0.01% 1353
2021
Q3
$3.33M Sell
59,510
-661
-1% -$38.1K ﹤0.01% 1400
2021
Q2
$3.65M Sell
60,171
-4,126
-6% -$261K ﹤0.01% 1386
2021
Q1
$4.51M Sell
64,297
-194
-0.3% -$13.9K 0.01% 1253
2020
Q4
$3.86M Buy
64,491
+1,004
+2% +$58.8K 0.01% 1257
2020
Q3
$3.82M Buy
63,487
+1,199
+2% +$69.7K 0.01% 1107
2020
Q2
$3.27M Hold
62,288
0.01% 1186
2020
Q1
$2.09M Sell
62,288
-309
-0.5% -$12.8K ﹤0.01% 1273
2019
Q4
$2.84M Sell
62,597
-599
-0.9% -$25.4K ﹤0.01% 1354
2019
Q3
$2.41M Buy
63,196
+755
+1% +$30.1K ﹤0.01% 1426
2019
Q2
$2.72M Buy
62,441
+1,347
+2% +$57.2K 0.01% 1368
2019
Q1
$2.33M Sell
61,094
-1,427
-2% -$55.7K ﹤0.01% 1443
2018
Q4
$2.69M Buy
62,521
+1,596
+3% +$74.5K 0.01% 1275
2018
Q3
$2.99M Sell
60,925
-147
-0.2% -$6.35K 0.01% 1363
2018
Q2
$1.96M Buy
61,072
+513
+0.8% +$17.7K ﹤0.01% 1627
2018
Q1
$1.89M Sell
60,559
-1,388
-2% -$49.4K ﹤0.01% 1569
2017
Q4
$2.83M Sell
61,947
-939
-1% -$37.2K 0.01% 1349
2017
Q3
$2.36M Sell
62,886
-6,690
-10% -$269K 0.01% 1452
2017
Q2
$3.32M Sell
69,576
-2,240
-3% -$104K 0.01% 1288
2017
Q1
$3.27M Sell
71,816
-3,300
-4% -$143K 0.01% 1345
2016
Q4
$2.43M Sell
75,116
-2,100
-3% -$70.1K ﹤0.01% 1537
2016
Q3
$2.64M Buy
77,216
+800
+1% +$31.3K 0.01% 1475
2016
Q2
$2.58M Sell
76,416
-1,041
-1% -$51.2K 0.01% 1452
2016
Q1
$4.1M Buy
77,457
+9,959
+15% +$583K 0.01% 1135
2015
Q4
$5.18M Buy
67,498
+1,040
+2% +$58.9K 0.01% 938
2015
Q3
$2.73M Sell
66,458
-100
-0.2% -$6.13K 0.01% 1335
2015
Q2
$4.71M Buy
66,558
+1,316
+2% +$104K 0.01% 1068
2015
Q1
$5.8M Sell
65,242
-1,200
-2% -$122K 0.01% 944
2014
Q4
$5.89M Buy
66,442
+581
+0.9% +$55K 0.01% 920
2014
Q3
$6.38M Buy
65,861
+774
+1% +$75.3K 0.02% 847
2014
Q2
$5.98M Buy
65,087
+15,000
+30% +$1.14M 0.02% 900
2014
Q1
$3.51M Buy
50,087
+200
+0.4% +$13.6K 0.01% 1155
2013
Q4
$2.87M Buy
49,887
+300
+0.6% +$15.8K 0.01% 1287
2013
Q3
$2.38M Buy
49,587
+1,563
+3% +$57K 0.01% 1352
2013
Q2
$1.39M Buy
+48,024
New +$1.39M ﹤0.01% 1639

Other funds holding PCRX